Gradient phenomenon of multidrug resistance gene expression in breast cancer during neoadjuvant chemotherapy is related to disease progression
The paper examined 106 patients with breast cancer (BC) treated with neoadjuvant chemotherapy (NАС). In the biopsy material, derived from primary tumor before NAC and surgical samples after chemotherapy the expression of 8 multidrug resistance genes (MDR) ABCB1, АВСВ2, ABCC1, ABCC2, АВСС5, ABCG1, AB...
Main Author: | N. V. Litviakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2016-02-01
|
Series: | Sibirskij Onkologičeskij Žurnal |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/162 |
Similar Items
-
The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer
by: Body A, et al.
Published: (2021-03-01) -
Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperatively
by: Michał Jarząb, et al.
Published: (2019-08-01) -
BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
by: M. M. Tsyganov, et al.
Published: (2018-05-01) -
The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
by: Oktay Üçer
Published: (2016-04-01) -
mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer
by: M. M. Tsyganov, et al.
Published: (2019-02-01)